-
Description
-
Table of Contents
-
Table of Figures
PDF Download
-
Description
-
Table of Contents
-
Table of Figures
- PDF Download
Description
The global market for Emphysema Treatment Medication was estimated to be worth US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Emphysema Treatment Medication Market Size(US$)
M= millions and B=billions
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Emphysema Treatment Medication by region & country, by Type, and by Application.
The Emphysema Treatment Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment Medication.
Market Segmentation
Report Metric
Details
Report Title
Emphysema Treatment Medication- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 5331 million
CAGR(2025-2031)
3.3%
Market Size Available for Years
2020-2031
Global Emphysema Treatment Medication Companies Covered
Emphasys Medical, Pfizer, Uptake Medical, Inogen, Inc, Viatris Inc, Boehringer Ingelheim International GmbH, Novartis AG, AstraZeneca, Orion Corporation, Teva Pharmaceutical Industries Ltd, Verona Pharma Plc, GlaxoSmithKline Plc, Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada
Global Emphysema Treatment Medication Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment Medication Market, Segment by Type
Global Emphysema Treatment Medication Market, Segment by Application
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Emphysema Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Emphysema Treatment Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Emphysema Treatment Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Emphysema Treatment Medication Product Introduction
1.2 Global Emphysema Treatment Medication Market Size Forecast (2020-2031)
1.3 Emphysema Treatment Medication Market Trends & Drivers
1.3.1 Emphysema Treatment Medication Industry Trends
1.3.2 Emphysema Treatment Medication Market Drivers & Opportunity
1.3.3 Emphysema Treatment Medication Market Challenges
1.3.4 Emphysema Treatment Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Emphysema Treatment Medication Players Revenue Ranking (2024)
2.2 Global Emphysema Treatment Medication Revenue by Company (2020-2025)
2.3 Key Companies Emphysema Treatment Medication Manufacturing Base Distribution and Headquarters
2.4 Key Companies Emphysema Treatment Medication Product Offered
2.5 Key Companies Time to Begin Mass Production of Emphysema Treatment Medication
2.6 Emphysema Treatment Medication Market Competitive Analysis
2.6.1 Emphysema Treatment Medication Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Emphysema Treatment Medication Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bronchodilators
3.1.2 Steroids
3.1.3 Others
3.2 Global Emphysema Treatment Medication Sales Value by Type
3.2.1 Global Emphysema Treatment Medication Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Emphysema Treatment Medication Sales Value, by Type (2020-2031)
3.2.3 Global Emphysema Treatment Medication Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Homecare
4.1.3 Others
4.2 Global Emphysema Treatment Medication Sales Value by Application
4.2.1 Global Emphysema Treatment Medication Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Emphysema Treatment Medication Sales Value, by Application (2020-2031)
4.2.3 Global Emphysema Treatment Medication Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Emphysema Treatment Medication Sales Value by Region
5.1.1 Global Emphysema Treatment Medication Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Emphysema Treatment Medication Sales Value by Region (2020-2025)
5.1.3 Global Emphysema Treatment Medication Sales Value by Region (2026-2031)
5.1.4 Global Emphysema Treatment Medication Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Emphysema Treatment Medication Sales Value, 2020-2031
5.2.2 North America Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Emphysema Treatment Medication Sales Value, 2020-2031
5.3.2 Europe Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Emphysema Treatment Medication Sales Value, 2020-2031
5.4.2 Asia Pacific Emphysema Treatment Medication Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Emphysema Treatment Medication Sales Value, 2020-2031
5.5.2 South America Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Emphysema Treatment Medication Sales Value, 2020-2031
5.6.2 Middle East & Africa Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Emphysema Treatment Medication Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Emphysema Treatment Medication Sales Value, 2020-2031
6.3 United States
6.3.1 United States Emphysema Treatment Medication Sales Value, 2020-2031
6.3.2 United States Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Emphysema Treatment Medication Sales Value, 2020-2031
6.4.2 Europe Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Emphysema Treatment Medication Sales Value, 2020-2031
6.5.2 China Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.5.3 China Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Emphysema Treatment Medication Sales Value, 2020-2031
6.6.2 Japan Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Emphysema Treatment Medication Sales Value, 2020-2031
6.7.2 South Korea Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Emphysema Treatment Medication Sales Value, 2020-2031
6.8.2 Southeast Asia Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Emphysema Treatment Medication Sales Value, 2020-2031
6.9.2 India Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
6.9.3 India Emphysema Treatment Medication Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Emphasys Medical
7.1.1 Emphasys Medical Profile
7.1.2 Emphasys Medical Main Business
7.1.3 Emphasys Medical Emphysema Treatment Medication Products, Services and Solutions
7.1.4 Emphasys Medical Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.1.5 Emphasys Medical Recent Developments
7.2 Pfizer
7.2.1 Pfizer Profile
7.2.2 Pfizer Main Business
7.2.3 Pfizer Emphysema Treatment Medication Products, Services and Solutions
7.2.4 Pfizer Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.2.5 Pfizer Recent Developments
7.3 Uptake Medical
7.3.1 Uptake Medical Profile
7.3.2 Uptake Medical Main Business
7.3.3 Uptake Medical Emphysema Treatment Medication Products, Services and Solutions
7.3.4 Uptake Medical Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.3.5 Uptake Medical Recent Developments
7.4 Inogen, Inc
7.4.1 Inogen, Inc Profile
7.4.2 Inogen, Inc Main Business
7.4.3 Inogen, Inc Emphysema Treatment Medication Products, Services and Solutions
7.4.4 Inogen, Inc Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.4.5 Inogen, Inc Recent Developments
7.5 Viatris Inc
7.5.1 Viatris Inc Profile
7.5.2 Viatris Inc Main Business
7.5.3 Viatris Inc Emphysema Treatment Medication Products, Services and Solutions
7.5.4 Viatris Inc Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.5.5 Viatris Inc Recent Developments
7.6 Boehringer Ingelheim International GmbH
7.6.1 Boehringer Ingelheim International GmbH Profile
7.6.2 Boehringer Ingelheim International GmbH Main Business
7.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Products, Services and Solutions
7.6.4 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.6.5 Boehringer Ingelheim International GmbH Recent Developments
7.7 Novartis AG
7.7.1 Novartis AG Profile
7.7.2 Novartis AG Main Business
7.7.3 Novartis AG Emphysema Treatment Medication Products, Services and Solutions
7.7.4 Novartis AG Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.7.5 Novartis AG Recent Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Profile
7.8.2 AstraZeneca Main Business
7.8.3 AstraZeneca Emphysema Treatment Medication Products, Services and Solutions
7.8.4 AstraZeneca Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.8.5 AstraZeneca Recent Developments
7.9 Orion Corporation
7.9.1 Orion Corporation Profile
7.9.2 Orion Corporation Main Business
7.9.3 Orion Corporation Emphysema Treatment Medication Products, Services and Solutions
7.9.4 Orion Corporation Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.9.5 Orion Corporation Recent Developments
7.10 Teva Pharmaceutical Industries Ltd
7.10.1 Teva Pharmaceutical Industries Ltd Profile
7.10.2 Teva Pharmaceutical Industries Ltd Main Business
7.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Products, Services and Solutions
7.10.4 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
7.11 Verona Pharma Plc
7.11.1 Verona Pharma Plc Profile
7.11.2 Verona Pharma Plc Main Business
7.11.3 Verona Pharma Plc Emphysema Treatment Medication Products, Services and Solutions
7.11.4 Verona Pharma Plc Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.11.5 Verona Pharma Plc Recent Developments
7.12 GlaxoSmithKline Plc
7.12.1 GlaxoSmithKline Plc Profile
7.12.2 GlaxoSmithKline Plc Main Business
7.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Products, Services and Solutions
7.12.4 GlaxoSmithKline Plc Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.12.5 GlaxoSmithKline Plc Recent Developments
7.13 Pulmonx
7.13.1 Pulmonx Profile
7.13.2 Pulmonx Main Business
7.13.3 Pulmonx Emphysema Treatment Medication Products, Services and Solutions
7.13.4 Pulmonx Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.13.5 Pulmonx Recent Developments
7.14 Bioxyne
7.14.1 Bioxyne Profile
7.14.2 Bioxyne Main Business
7.14.3 Bioxyne Emphysema Treatment Medication Products, Services and Solutions
7.14.4 Bioxyne Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.14.5 Bioxyne Recent Developments
7.15 Intrexon
7.15.1 Intrexon Profile
7.15.2 Intrexon Main Business
7.15.3 Intrexon Emphysema Treatment Medication Products, Services and Solutions
7.15.4 Intrexon Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.15.5 Intrexon Recent Developments
7.16 Icure Pharmaceuticals
7.16.1 Icure Pharmaceuticals Profile
7.16.2 Icure Pharmaceuticals Main Business
7.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Products, Services and Solutions
7.16.4 Icure Pharmaceuticals Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.16.5 Icure Pharmaceuticals Recent Developments
7.17 Kamada
7.17.1 Kamada Profile
7.17.2 Kamada Main Business
7.17.3 Kamada Emphysema Treatment Medication Products, Services and Solutions
7.17.4 Kamada Emphysema Treatment Medication Revenue (US$ Million) & (2020-2025)
7.17.5 Kamada Recent Developments
8 Industry Chain Analysis
8.1 Emphysema Treatment Medication Industrial Chain
8.2 Emphysema Treatment Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Emphysema Treatment Medication Sales Model
8.5.2 Sales Channel
8.5.3 Emphysema Treatment Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Emphysema Treatment Medication Market Trends
Table 2. Emphysema Treatment Medication Market Drivers & Opportunity
Table 3. Emphysema Treatment Medication Market Challenges
Table 4. Emphysema Treatment Medication Market Restraints
Table 5. Global Emphysema Treatment Medication Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Emphysema Treatment Medication Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Emphysema Treatment Medication Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Emphysema Treatment Medication Product Type
Table 9. Key Companies Time to Begin Mass Production of Emphysema Treatment Medication
Table 10. Global Emphysema Treatment Medication Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Emphysema Treatment Medication Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Emphysema Treatment Medication Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Emphysema Treatment Medication Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Emphysema Treatment Medication Sales Market Share in Value by Type (2020-2025)
Table 17. Global Emphysema Treatment Medication Sales Market Share in Value by Type (2026-2031)
Table 18. Global Emphysema Treatment Medication Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Emphysema Treatment Medication Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Emphysema Treatment Medication Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Emphysema Treatment Medication Sales Market Share in Value by Application (2020-2025)
Table 22. Global Emphysema Treatment Medication Sales Market Share in Value by Application (2026-2031)
Table 23. Global Emphysema Treatment Medication Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Emphysema Treatment Medication Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Emphysema Treatment Medication Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Emphysema Treatment Medication Sales Value by Region (2020-2025) & (%)
Table 27. Global Emphysema Treatment Medication Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Emphysema Treatment Medication Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Emphysema Treatment Medication Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Emphysema Treatment Medication Sales Value, (2026-2031) & (US$ Million)
Table 31. Emphasys Medical Basic Information List
Table 32. Emphasys Medical Description and Business Overview
Table 33. Emphasys Medical Emphysema Treatment Medication Products, Services and Solutions
Table 34. Revenue (US$ Million) in Emphysema Treatment Medication Business of Emphasys Medical (2020-2025)
Table 35. Emphasys Medical Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Emphysema Treatment Medication Products, Services and Solutions
Table 39. Revenue (US$ Million) in Emphysema Treatment Medication Business of Pfizer (2020-2025)
Table 40. Pfizer Recent Developments
Table 41. Uptake Medical Basic Information List
Table 42. Uptake Medical Description and Business Overview
Table 43. Uptake Medical Emphysema Treatment Medication Products, Services and Solutions
Table 44. Revenue (US$ Million) in Emphysema Treatment Medication Business of Uptake Medical (2020-2025)
Table 45. Uptake Medical Recent Developments
Table 46. Inogen, Inc Basic Information List
Table 47. Inogen, Inc Description and Business Overview
Table 48. Inogen, Inc Emphysema Treatment Medication Products, Services and Solutions
Table 49. Revenue (US$ Million) in Emphysema Treatment Medication Business of Inogen, Inc (2020-2025)
Table 50. Inogen, Inc Recent Developments
Table 51. Viatris Inc Basic Information List
Table 52. Viatris Inc Description and Business Overview
Table 53. Viatris Inc Emphysema Treatment Medication Products, Services and Solutions
Table 54. Revenue (US$ Million) in Emphysema Treatment Medication Business of Viatris Inc (2020-2025)
Table 55. Viatris Inc Recent Developments
Table 56. Boehringer Ingelheim International GmbH Basic Information List
Table 57. Boehringer Ingelheim International GmbH Description and Business Overview
Table 58. Boehringer Ingelheim International GmbH Emphysema Treatment Medication Products, Services and Solutions
Table 59. Revenue (US$ Million) in Emphysema Treatment Medication Business of Boehringer Ingelheim International GmbH (2020-2025)
Table 60. Boehringer Ingelheim International GmbH Recent Developments
Table 61. Novartis AG Basic Information List
Table 62. Novartis AG Description and Business Overview
Table 63. Novartis AG Emphysema Treatment Medication Products, Services and Solutions
Table 64. Revenue (US$ Million) in Emphysema Treatment Medication Business of Novartis AG (2020-2025)
Table 65. Novartis AG Recent Developments
Table 66. AstraZeneca Basic Information List
Table 67. AstraZeneca Description and Business Overview
Table 68. AstraZeneca Emphysema Treatment Medication Products, Services and Solutions
Table 69. Revenue (US$ Million) in Emphysema Treatment Medication Business of AstraZeneca (2020-2025)
Table 70. AstraZeneca Recent Developments
Table 71. Orion Corporation Basic Information List
Table 72. Orion Corporation Description and Business Overview
Table 73. Orion Corporation Emphysema Treatment Medication Products, Services and Solutions
Table 74. Revenue (US$ Million) in Emphysema Treatment Medication Business of Orion Corporation (2020-2025)
Table 75. Orion Corporation Recent Developments
Table 76. Teva Pharmaceutical Industries Ltd Basic Information List
Table 77. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 78. Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Products, Services and Solutions
Table 79. Revenue (US$ Million) in Emphysema Treatment Medication Business of Teva Pharmaceutical Industries Ltd (2020-2025)
Table 80. Teva Pharmaceutical Industries Ltd Recent Developments
Table 81. Verona Pharma Plc Basic Information List
Table 82. Verona Pharma Plc Description and Business Overview
Table 83. Verona Pharma Plc Emphysema Treatment Medication Products, Services and Solutions
Table 84. Revenue (US$ Million) in Emphysema Treatment Medication Business of Verona Pharma Plc (2020-2025)
Table 85. Verona Pharma Plc Recent Developments
Table 86. GlaxoSmithKline Plc Basic Information List
Table 87. GlaxoSmithKline Plc Description and Business Overview
Table 88. GlaxoSmithKline Plc Emphysema Treatment Medication Products, Services and Solutions
Table 89. Revenue (US$ Million) in Emphysema Treatment Medication Business of GlaxoSmithKline Plc (2020-2025)
Table 90. GlaxoSmithKline Plc Recent Developments
Table 91. Pulmonx Basic Information List
Table 92. Pulmonx Description and Business Overview
Table 93. Pulmonx Emphysema Treatment Medication Products, Services and Solutions
Table 94. Revenue (US$ Million) in Emphysema Treatment Medication Business of Pulmonx (2020-2025)
Table 95. Pulmonx Recent Developments
Table 96. Bioxyne Basic Information List
Table 97. Bioxyne Description and Business Overview
Table 98. Bioxyne Emphysema Treatment Medication Products, Services and Solutions
Table 99. Revenue (US$ Million) in Emphysema Treatment Medication Business of Bioxyne (2020-2025)
Table 100. Bioxyne Recent Developments
Table 101. Intrexon Basic Information List
Table 102. Intrexon Description and Business Overview
Table 103. Intrexon Emphysema Treatment Medication Products, Services and Solutions
Table 104. Revenue (US$ Million) in Emphysema Treatment Medication Business of Intrexon (2020-2025)
Table 105. Intrexon Recent Developments
Table 106. Icure Pharmaceuticals Basic Information List
Table 107. Icure Pharmaceuticals Description and Business Overview
Table 108. Icure Pharmaceuticals Emphysema Treatment Medication Products, Services and Solutions
Table 109. Revenue (US$ Million) in Emphysema Treatment Medication Business of Icure Pharmaceuticals (2020-2025)
Table 110. Icure Pharmaceuticals Recent Developments
Table 111. Kamada Basic Information List
Table 112. Kamada Description and Business Overview
Table 113. Kamada Emphysema Treatment Medication Products, Services and Solutions
Table 114. Revenue (US$ Million) in Emphysema Treatment Medication Business of Kamada (2020-2025)
Table 115. Kamada Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Emphysema Treatment Medication Downstream Customers
Table 119. Emphysema Treatment Medication Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Emphysema Treatment Medication Product Picture
Figure 2. Global Emphysema Treatment Medication Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Emphysema Treatment Medication Sales Value (2020-2031) & (US$ Million)
Figure 4. Emphysema Treatment Medication Report Years Considered
Figure 5. Global Emphysema Treatment Medication Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Emphysema Treatment Medication Revenue in 2024
Figure 7. Emphysema Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Bronchodilators Picture
Figure 9. Steroids Picture
Figure 10. Others Picture
Figure 11. Global Emphysema Treatment Medication Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Emphysema Treatment Medication Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Homecare
Figure 15. Product Picture of Others
Figure 16. Global Emphysema Treatment Medication Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Emphysema Treatment Medication Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Emphysema Treatment Medication Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Emphysema Treatment Medication Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Emphysema Treatment Medication Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Emphysema Treatment Medication Sales Value (%), (2020-2031)
Figure 29. United States Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 35. China Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 37. China Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 47. India Emphysema Treatment Medication Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Emphysema Treatment Medication Sales Value by Type (%), 2024 VS 2031
Figure 49. India Emphysema Treatment Medication Sales Value by Application (%), 2024 VS 2031
Figure 50. Emphysema Treatment Medication Industrial Chain
Figure 51. Emphysema Treatment Medication Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Description
The global market for Emphysema Treatment Medication was estimated to be worth US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Emphysema Treatment Medication by region & country, by Type, and by Application.
The Emphysema Treatment Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment Medication.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Emphysema Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Emphysema Treatment Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Emphysema Treatment Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
0
